218 related articles for article (PubMed ID: 8655983)
1. Oral immunization of mice against candidiasis.
Jensen J; Warner T; Johnson C; Balish E
J Infect Dis; 1996 Jul; 174(1):133-40. PubMed ID: 8655983
[TBL] [Abstract][Full Text] [Related]
2. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with Secreted Aspartyl Proteinase 2 Protein from
Shukla M; Rohatgi S
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125
[TBL] [Abstract][Full Text] [Related]
4. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
[TBL] [Abstract][Full Text] [Related]
5. Impaired immune response to Candida albicans in aged mice.
Murciano C; Villamón E; Yáñez A; O'Connor JE; Gozalbo D; Gil ML
J Med Microbiol; 2006 Dec; 55(Pt 12):1649-1656. PubMed ID: 17108267
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon gamma receptor protein.
Londono LP; Jones HB; Vie AT; McPheat WL; Booth G; Gao XM; Dougan G
FEMS Immunol Med Microbiol; 2000 Feb; 27(2):117-25. PubMed ID: 10640606
[TBL] [Abstract][Full Text] [Related]
7. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.
Bromuro C; Torosantucci A; Chiani P; Conti S; Polonelli L; Cassone A
Infect Immun; 2002 Oct; 70(10):5462-70. PubMed ID: 12228271
[TBL] [Abstract][Full Text] [Related]
8. Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein.
Tavares D; Ferreira P; Arala-Chaves M
Microbiology (Reading); 2003 Feb; 149(Pt 2):333-339. PubMed ID: 12624195
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rd induces protective anti-Candida albicans antibody through immunological adjuvant activity.
Han Y; Rhew KY
Int Immunopharmacol; 2013 Nov; 17(3):651-7. PubMed ID: 24007781
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of fungal extracellular vesicles against murine candidiasis.
Vargas G; Honorato L; Guimarães AJ; Rodrigues ML; Reis FCG; Vale AM; Ray A; Nosanchuk JD; Nimrichter L
Cell Microbiol; 2020 Oct; 22(10):e13238. PubMed ID: 32558196
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis.
Montagnoli C; Sandini S; Bacci A; Romani L; La Valle R
Med Mycol; 2004 Aug; 42(4):319-24. PubMed ID: 15473356
[TBL] [Abstract][Full Text] [Related]
12. Active and passive immunization against oral Candida albicans infection in a murine model.
Farah CS; Ashman RB
Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
[TBL] [Abstract][Full Text] [Related]
13. Serum antibody response of gnotobiotic athymic and euthymic mice following alimentary tract colonization and infection with Candida albicans.
Balish E; Filutowicz H
Can J Microbiol; 1991 Mar; 37(3):204-10. PubMed ID: 2054747
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of germfree phagocyte oxidase- and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin.
Balish E; Warner TF; Nicholas PJ; Paulling EE; Westwater C; Schofield DA
Infect Immun; 2005 Mar; 73(3):1313-20. PubMed ID: 15731028
[TBL] [Abstract][Full Text] [Related]
15. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development.
Cenci E; Mencacci A; Spaccapelo R; Tonnetti L; Mosci P; Enssle KH; Puccetti P; Romani L; Bistoni F
J Infect Dis; 1995 May; 171(5):1279-88. PubMed ID: 7751704
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
Han Y; Rhew KY
Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
[TBL] [Abstract][Full Text] [Related]
17. Humoral and cellular immune responses to enolase after alimentary tract colonization or intravenous immunization with Candida albicans.
Sundstrom P; Jensen J; Balish E
J Infect Dis; 1994 Aug; 170(2):390-5. PubMed ID: 8035025
[TBL] [Abstract][Full Text] [Related]
18. Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.
Cutler JE; Corti M; Lambert P; Ferris M; Xin H
PLoS One; 2011; 6(7):e22030. PubMed ID: 21818288
[TBL] [Abstract][Full Text] [Related]
19. B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis.
Wagner RD; Vazquez-Torres A; Jones-Carson J; Warner T; Balish E
J Infect Dis; 1996 Sep; 174(3):589-97. PubMed ID: 8769618
[TBL] [Abstract][Full Text] [Related]
20. Serum Antibody Profile during Colonization of the Mouse Gut by Candida albicans: Relevance for Protection during Systemic Infection.
Huertas B; Prieto D; Pitarch A; Gil C; Pla J; Díez-Orejas R
J Proteome Res; 2017 Jan; 16(1):335-345. PubMed ID: 27539120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
